EdgarLookup

Theravance Biopharma, Inc. — SC 13G Filings

15 SC 13G filings on record

This page lists all SC 13G filings submitted to the SEC by Theravance Biopharma, Inc. (TBPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Theravance Biopharma, Inc. has filed 15 SC 13G documents with the SEC since 2015. To view all SEC filings by Theravance Biopharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-12B 10-12B/A 10-K 10-Q 10-Q/A 144 3 3/A 4 4/A 424B5 8-A12B 8-K 8-K/A CERTNAS CORRESP CT ORDER DEF 14A DEFA14A EFFECT FWP PRE 14A S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G 0001493152-24-032810 Aug 16, 2024
SC 13G 0001493152-24-006592 Feb 14, 2024
SC 13G 0001357550-22-000103 Jun 16, 2022
SC 13G SC 13G 0001104659-22-048217 Apr 21, 2022
SC 13G 0001013594-21-000722 Sep 27, 2021
SC 13G SCHEDULE 13G 0000899140-21-000633 Sep 7, 2021
SC 13G SCHEDULE 13G 0000947871-21-000186 Feb 12, 2021
SC 13G SEC SCHEDULE 13G 0000902219-20-000198 Jan 28, 2020
SC 13G SC 13G 0001193125-19-277660 Oct 29, 2019
SC 13G 0000932471-17-001931 Feb 10, 2017
SC 13G 0000315066-16-006360 Nov 10, 2016
SC 13G SCHEDULE 13G 0001213900-15-008375 Nov 10, 2015
SC 13G SCHEDULE 13G 0001213900-15-008373 Nov 10, 2015
SC 13G NONE 0001140361-15-006561 Feb 13, 2015
SC 13G 0001086364-15-001794 Feb 2, 2015